Boston Scientific Corporation Stock
Equities
BSX
US1011371077
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
90.43 USD | -0.25% | +1.32% | +56.43% |
Nov. 25 | Boston Scientific to Buy Intera Oncology | MT |
Nov. 25 | Boston Scientific Corporation has entered into a definitive agreement to acquire Intera Oncology Inc. | CI |
Capitalization | 134B 127B 118B 106B 188B 11,323B 206B 1,468B 545B 4,636B 502B 491B 19,978B | P/E ratio 2024 * |
68x | P/E ratio 2025 * | 47.9x |
---|---|---|---|---|---|
Enterprise value | 141B 134B 125B 111B 197B 11,914B 217B 1,545B 573B 4,878B 528B 516B 21,021B | EV / Sales 2024 * |
8.48x | EV / Sales 2025 * | 7.38x |
Free-Float |
84.69% | Yield 2024 * |
-
| Yield 2025 * | - |
Last Transcript: Boston Scientific Corporation
1 day | -0.25% | ||
1 week | +0.48% | ||
Current month | -0.25% | ||
1 month | +8.14% | ||
3 months | +10.56% | ||
6 months | +19.66% | ||
Current year | +56.43% |
Director | Title | Age | Since |
---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 59 | 2011-10-31 |
Daniel Brennan
DFI | Director of Finance/CFO | 58 | 2013-12-30 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 2009-08-31 |
Manager | Title | Age | Since |
---|---|---|---|
John Sununu
BRD | Director/Board Member | 59 | 2009-03-31 |
Michael Mahoney
CHM | Chairman | 59 | 2016-05-02 |
Edward Ludwig
BRD | Director/Board Member | 72 | 2014-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.26% | 12 M€ | +15.09% | - | |
1.98% | 1 M€ | +2.21% | - | |
1.75% | 20 M€ | +15.66% | - |
Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
---|---|---|---|---|---|---|
-0.25% | +0.48% | +61.08% | +137.10% | 134B | ||
+0.06% | +3.25% | +6.82% | -15.36% | 203B | ||
+0.16% | -0.92% | +72.22% | +69.68% | 193B | ||
+0.67% | +2.31% | +7.97% | -24.53% | 173B | ||
+0.97% | +4.06% | -2.52% | -20.28% | 60.6B | ||
+1.04% | -0.04% | -9.27% | -26.59% | 43.5B | ||
-1.15% | +0.07% | +3.17% | -34.35% | 42.08B | ||
+1.17% | +4.29% | +8.38% | -5.82% | 39.35B | ||
-0.17% | +0.78% | +19.69% | - | 38.02B | ||
-1.65% | +0.47% | +53.42% | -3.30% | 36.54B | ||
Average | +0.09% | +1.37% | +22.10% | +8.50% | 96.25B | |
Weighted average by Cap. | +0.17% | +1.29% | +28.54% | +21.88% |
2024 * | 2025 * | |
---|---|---|
Net sales | 16.58B 15.79B 14.69B 13.1B 23.28B 1,405B 25.61B 182B 67.62B 575B 62.23B 60.9B 2,479B | 18.62B 17.74B 16.51B 14.72B 26.15B 1,578B 28.76B 205B 75.96B 646B 69.9B 68.4B 2,784B |
Net income | 1.98B 1.88B 1.75B 1.56B 2.78B 168B 3.05B 21.72B 8.06B 68.59B 7.42B 7.26B 296B | 2.84B 2.71B 2.52B 2.25B 3.99B 241B 4.39B 31.24B 11.6B 98.65B 10.67B 10.44B 425B |
Net Debt | 6.98B 6.64B 6.18B 5.51B 9.79B 591B 10.77B 76.64B 28.45B 242B 26.18B 25.62B 1,043B | 3.89B 3.71B 3.45B 3.08B 5.47B 330B 6.01B 42.78B 15.88B 135B 14.62B 14.3B 582B |
Date | Price | Change | Volume |
---|---|---|---|
24-12-02 | 90.43 $ | -0.25% | 3,387,968 |
24-11-29 | 90.66 $ | -0.10% | 3,446,971 |
24-11-27 | 90.75 $ | +0.60% | 3,788,570 |
24-11-26 | 90.21 $ | +1.08% | 4,284,463 |
Delayed Quote Nyse, December 02, 2024 at 04:00 pm EST
More quotesQuarterly revenue - Rate of surprise
- Stock Market
- Equities
- BSX Stock